Over 61% of Pharmaceutical Caps and Closures Sales Reliant on Surging Demand for Child-Resistance Packaging: FMI
Over 61% of Pharmaceutical Caps and Closures Sales Reliant on Surging Demand for Child-Resistance Packaging: FMI
Published by mark itwired
Posted on September 20, 2021
According to ESOMAR-certified consulting firm Future Market Insights, the global pharmaceutical caps and closure market is slated to increase, expanding at a CAGR of 5% in 2021.
The market is anticipated to surpass a valuation of US$ 2.27 billion by 2021-end on the back of growing demand of safe and easy packaging solutions of pharmaceuticals. Growing demand of child-proof packaging due to the rising concern of accidental consumption will spur the growth.
Expansion of pharmaceutical sector across developed regions such as the U.S., U.K., and Germany is enabling the growth of market. Also, focus on effective packaging to lessen the spoilage of pharmaceutical drugs will improve the adoption of pharmaceutical caps and closures.
Sustainability concerns and easy availability have increased the demand of lightweight packaging, especially plastic pharmaceutical caps and closures. However, stringent regulations associated with use of plastics within pharmaceutical and food & beverage industries might impede the market growth.
Furthermore, rising prevalence of chronic diseases such as cardiovascular disease and other diseases have increased the demand for various medications. This in turn, is enabling the demand for effective packaging solutions in the pharmaceutical sector, widening the growth opportunities for the market players.
Advancement in technology and need for smart yet cost-effective packaging is anticipated to fuel the demand of pharmaceutical caps & closures during the forecast period. Smart packaging is needed for the safety and to maintain the quality of product without any accidental consumption of drugs by children.
Considering this, demand for tamper-resistant and child-resistant pharmaceutical caps and closures will bolster the market growth throughout the forecast period. As per the FMI’s analysis, child resistance functionality segment is expected to register maximum growth in the pharmaceutical caps and closure market.
“Rising demand for smart and safe packaging solutions within the pharmaceutical sector is creating growth opportunities for market players throughout the forecast period,” says the FMI analyst.
Key Takeaways from FMI’s Pharmaceutical Caps and Closures Market Study
In terms of functionality, child resistance closures is anticipated to be one of the most lucrative segment, accounting for over 61% market sales
Screw cap and closures are leading the product type segment and will account for more than 46% of market share through 2031
By material, plastic caps and closure account for maximum sales of over 64% during the forecast period
Anti-cancer drugs segment will exhibit faster growth, registering a CAGR of around 7.5% over the forecast period
Small molecule drug modalities segment will witness a steady growth and will account for 60% of global market share
The U.S. will emerge as the most lucrative market of pharmaceutical caps and closures, accounting for over 89% of market share
Heavy presence of leading players and improvement in production capacities across U.K. will bolster the market growth
Germany will emerge as potential market, registering a growth of 6.7% throughout the forecast period
Increased healthcare and pharmaceutical expenditure in Japan will stimulate the sales of pharmaceutical caps and closure within the country
China will lead the pharmaceutical caps and closure market in East Asia, exhibiting a growth of 8% CAGR through 2021
Competitive Landscape
Prominent manufacturers are strengthening their market presence through strategic collaborations and acquisition of various other organizations. Increasing research & development activities carried out by the leading players will consolidate the growth in fragmented market, opines FMI’s ma
In July 2019, Berry Global Group announced the acquisition of RPC Group for US$ 6.5 billion, making the company a leading global supplier of value-added protective solutions and one of the world’s largest plastic packaging companies. Also, the company broadened its global footprint consisting of over 290 locations worldwide, including in North America, Europe, Asia, Africa, Latin America and Australia.
Some of the prominent market players profiled by Future Market Insights operating in pharmaceutical caps and closure market include:
More Insights on the Global Pharmaceutical Caps and Closures Market
In its latest report on global pharmaceutical caps and closure market, FMI provides deeper insights on the key trends of the market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of:
Product type
Screw Caps & Closure
Snap Caps & Closure
Push-Pull Caps & Closure
Stopper & Seals
Others
Functionality
Child Resistant
Tamper-evident
Material type
Plastic
Elastomer
Metal
Availability
Prescription (Rx) Pharmaceuticals
“Over-the-Counter (OTC) Pharmaceuticals”
Drug Modality
Small Molecule (Synthetic Drugs)
Biopharmaceuticals
Therapeutic Class
Anticancer Drugs
Anti-Infective Drugs
Anti-viral Drugs
Anti-bacterial Drugs
Anti-fungal Drugs
Others
Cardiovascular Drugs
Anti-inflammatory Drugs
Analgesics Drugs
Anti-diabetics
Ophthalmic Drugs
Neurological Drugs
Others
End Users
Pharmaceutical & Biotechnology Companies
Contract Manufacturing Organizations (CMO)
Contract Research Organization (CRO)
Academic & Research Institutes
Region
North America
Latin America
Europe
East Asia
South Asia
Middle East and Africa (MEA)
Oceania
Key Questions Covered in the Report
Which is the most preferred type of pharmaceutical caps and closures?
Which application will bolster the growth of pharmaceutical caps and closures market?
Which are the key trend that will drive the pharmaceutical caps and closures market demand?
What are the challenges that will affect the growth of pharmaceutical caps and closures market?
Which region will remain the most lucrative throughout the forecast period?
What is the impact of Covid-19 on pharmaceutical caps and closure market?
According to ESOMAR-certified consulting firm Future Market Insights, the global pharmaceutical caps and closure market is slated to increase, expanding at a CAGR of 5% in 2021.
The market is anticipated to surpass a valuation of US$ 2.27 billion by 2021-end on the back of growing demand of safe and easy packaging solutions of pharmaceuticals. Growing demand of child-proof packaging due to the rising concern of accidental consumption will spur the growth.
Expansion of pharmaceutical sector across developed regions such as the U.S., U.K., and Germany is enabling the growth of market. Also, focus on effective packaging to lessen the spoilage of pharmaceutical drugs will improve the adoption of pharmaceutical caps and closures.
Sustainability concerns and easy availability have increased the demand of lightweight packaging, especially plastic pharmaceutical caps and closures. However, stringent regulations associated with use of plastics within pharmaceutical and food & beverage industries might impede the market growth.
Furthermore, rising prevalence of chronic diseases such as cardiovascular disease and other diseases have increased the demand for various medications. This in turn, is enabling the demand for effective packaging solutions in the pharmaceutical sector, widening the growth opportunities for the market players.
Advancement in technology and need for smart yet cost-effective packaging is anticipated to fuel the demand of pharmaceutical caps & closures during the forecast period. Smart packaging is needed for the safety and to maintain the quality of product without any accidental consumption of drugs by children.
Considering this, demand for tamper-resistant and child-resistant pharmaceutical caps and closures will bolster the market growth throughout the forecast period. As per the FMI’s analysis, child resistance functionality segment is expected to register maximum growth in the pharmaceutical caps and closure market.
“Rising demand for smart and safe packaging solutions within the pharmaceutical sector is creating growth opportunities for market players throughout the forecast period,” says the FMI analyst.
Key Takeaways from FMI’s Pharmaceutical Caps and Closures Market Study
In terms of functionality, child resistance closures is anticipated to be one of the most lucrative segment, accounting for over 61% market sales
Screw cap and closures are leading the product type segment and will account for more than 46% of market share through 2031
By material, plastic caps and closure account for maximum sales of over 64% during the forecast period
Anti-cancer drugs segment will exhibit faster growth, registering a CAGR of around 7.5% over the forecast period
Small molecule drug modalities segment will witness a steady growth and will account for 60% of global market share
The U.S. will emerge as the most lucrative market of pharmaceutical caps and closures, accounting for over 89% of market share
Heavy presence of leading players and improvement in production capacities across U.K. will bolster the market growth
Germany will emerge as potential market, registering a growth of 6.7% throughout the forecast period
Increased healthcare and pharmaceutical expenditure in Japan will stimulate the sales of pharmaceutical caps and closure within the country
China will lead the pharmaceutical caps and closure market in East Asia, exhibiting a growth of 8% CAGR through 2021
Competitive Landscape
Prominent manufacturers are strengthening their market presence through strategic collaborations and acquisition of various other organizations. Increasing research & development activities carried out by the leading players will consolidate the growth in fragmented market, opines FMI’s ma
In July 2019, Berry Global Group announced the acquisition of RPC Group for US$ 6.5 billion, making the company a leading global supplier of value-added protective solutions and one of the world’s largest plastic packaging companies. Also, the company broadened its global footprint consisting of over 290 locations worldwide, including in North America, Europe, Asia, Africa, Latin America and Australia.
Some of the prominent market players profiled by Future Market Insights operating in pharmaceutical caps and closure market include:
More Insights on the Global Pharmaceutical Caps and Closures Market
In its latest report on global pharmaceutical caps and closure market, FMI provides deeper insights on the key trends of the market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of:
Product type
Screw Caps & Closure
Snap Caps & Closure
Push-Pull Caps & Closure
Stopper & Seals
Others
Functionality
Child Resistant
Tamper-evident
Material type
Plastic
Elastomer
Metal
Availability
Prescription (Rx) Pharmaceuticals
“Over-the-Counter (OTC) Pharmaceuticals”
Drug Modality
Small Molecule (Synthetic Drugs)
Biopharmaceuticals
Therapeutic Class
Anticancer Drugs
Anti-Infective Drugs
Anti-viral Drugs
Anti-bacterial Drugs
Anti-fungal Drugs
Others
Cardiovascular Drugs
Anti-inflammatory Drugs
Analgesics Drugs
Anti-diabetics
Ophthalmic Drugs
Neurological Drugs
Others
End Users
Pharmaceutical & Biotechnology Companies
Contract Manufacturing Organizations (CMO)
Contract Research Organization (CRO)
Academic & Research Institutes
Region
North America
Latin America
Europe
East Asia
South Asia
Middle East and Africa (MEA)
Oceania
Key Questions Covered in the Report
Which is the most preferred type of pharmaceutical caps and closures?
Which application will bolster the growth of pharmaceutical caps and closures market?
Which are the key trend that will drive the pharmaceutical caps and closures market demand?
What are the challenges that will affect the growth of pharmaceutical caps and closures market?
Which region will remain the most lucrative throughout the forecast period?
What is the impact of Covid-19 on pharmaceutical caps and closure market?